Anthony Chalmers
Oncology
Sentinel ONCOLOGY
United States of America
Biography
He is an acknowledged international leader in the field of radiotherapy/chemotherapy/PARP inhibitor combinations. He is Chair of the Novel Agents and Translational Sub-Group of the NCRI Brain Tumour Clinical Studies Group, Chair of the CRUK-NCRI Radiotherapy-Drug Combinations Consortium (RaDCom), Deputy Chair of the NCRI Clinical and Translational Radiotherapy Research Working Group (CTRad) and Vice-Chair of CRUK’s Clinical Trials Awards and Advisory Committee (CTAAC)
Research Interest
Radiotheraphy
